46 min

OsteoBites S1 Ep7: Osteosarcoma Research, Matteo Trucco, MD MIB Agents OsteoBites

    • Medicine

MIB Agents Osteosarcoma Webinar Series:  Dr. Matteo Trucco shares an update on his osteosarcoma research, funded by MIB Agents:  "Disulfiram to Overcome Chemo Resistance".  After a  presentation on this research, Dr. Trucco answers questions from attendees.
...
Guest Information: Matteo Trucco, MD
Director Children's Cancer Innovative Therapy Program
Associate Staff, Peds Hematology-Oncology & BMT   
Cleveland Clinic Children's  
...
OsteoBites Panelists are Amanda Braunfeld Levine of the closed FB group "Bone Cancer Support...for lives touched by Osteosarcoma & Ewing Sarcoma" and Florencia Pistritto of the Facebook Group "Osteosarcoma and Ewing's Sarcoma Support Group" and Liz Vallejo, MIB Agents Program Chief. Hosted by Ann Graham, President of MIB Agents.  MIB Agents is a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer.  More information at www.mibagents.org

MIB Agents Osteosarcoma Webinar Series:  Dr. Matteo Trucco shares an update on his osteosarcoma research, funded by MIB Agents:  "Disulfiram to Overcome Chemo Resistance".  After a  presentation on this research, Dr. Trucco answers questions from attendees.
...
Guest Information: Matteo Trucco, MD
Director Children's Cancer Innovative Therapy Program
Associate Staff, Peds Hematology-Oncology & BMT   
Cleveland Clinic Children's  
...
OsteoBites Panelists are Amanda Braunfeld Levine of the closed FB group "Bone Cancer Support...for lives touched by Osteosarcoma & Ewing Sarcoma" and Florencia Pistritto of the Facebook Group "Osteosarcoma and Ewing's Sarcoma Support Group" and Liz Vallejo, MIB Agents Program Chief. Hosted by Ann Graham, President of MIB Agents.  MIB Agents is a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer.  More information at www.mibagents.org

46 min